Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma - Quiz - MDSpire

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

UCI Health medical oncologist Poorva Vaidya, MD is currently offering a new clinical trial sponsored by the UC Irvine Anti-Cancer Challenge, and lead by Warren Chow, MD, aimed at tackling a persistent challenge in melanoma care if patients fail first-line immunotherapy.

  • June 24, 2026

Share

Original Source(s)

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

  • June 24, 2026

Related Content

Breast Cancer Incidence in Asian American, Native Hawaiian, and Pacific Islander Populations

Artificial intelligence for triple-negative breast cancer from imaging to multi-omics

Robot-assisted laparoscopic resection of giant pelvic solitary fibrous tumor: a case report with literature review